AT 007

· Applied Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AT 007, covering 2022-06-14 to 2026-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency [Phase 2, Phase 3]

See pricing